Impella®-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial,
Role: Investigator,
ABIOMED, Inc.,
(12/2025 - 12/2026)
Status: Approved
The impact of loading versus no loading dose NOAC in venous thromboembolism post -heart transplantation,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(10/2026)
Status: Approved